Related Experiment Videos
Monoclonal antibodies
The Journal of Infectious Diseases
|March 1, 1981
Summary
A novel technology enables the indefinite, large-scale production of homogeneous antibodies. This advancement enhances the reliability and sensitivity of immunoassays for infectious disease diagnostics and research.
Area of Science:
- Immunology
- Biotechnology
- Infectious Disease Diagnostics
Background:
- Serologic reagents are crucial for diagnosing, treating, and understanding infectious disease patterns.
- Current antibody production methods can be limited in scale and availability.
Purpose of the Study:
- To introduce a new technology for generating homogeneous antibodies.
- To highlight the potential of this technology to improve immunoassays and in vivo applications.
Main Methods:
- Development of a novel antibody generation technique.
- Focus on achieving homogeneous antibody production in large, indefinite quantities.
Main Results:
- Successful generation of homogeneous antibodies using the new technology.
- Demonstrated potential for large-scale and indefinite antibody availability.
Conclusions:
- The developed technology offers a reliable and sensitive source of antibodies for immunoassays.
- This advancement may lead to safer in vivo applications and improved infectious disease management.